drug
KITE-363
Phase 2updated 3mo agoby Kite Pharma Inc
Phase 2community read0 votes
indications
indications
DLBCL
all catalysts(0)
nothing on the calendar yet
Trials studying KITE-363
- phase1A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- phase2Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- phase1A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
- —Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 31m ago
Found something off?
comments(0)
5-min edit window · permanent after that